Journal
NATURE
Volume 480, Issue 7377, Pages 336-U86Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nature10696
Keywords
-
Categories
Funding
- National Institutes of Health (NIH)
- International AIDS Vaccine Initiative
- Ragon Institute
- Canadian Institute of Health Research
- NIH through the National Center for Research Resources [RR017573]
- US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]
Ask authors/readers for more resources
Variable regions 1 and 2 (V1/V2) of human immunodeficiency virus-1 (HIV-1) gp120 envelope glycoprotein are critical for viral evasion of antibody neutralization, and are themselves protected by extraordinary sequence diversity and N-linked glycosylation. Human antibodies such as PG9 nonetheless engage V1/V2 and neutralize 80% of HIV-1 isolates. Here we report the structure of V1/V2 in complex with PG9. V1/V2 forms a four-stranded beta-sheet domain, in which sequence diversity and glycosylation are largely segregated to strand-connecting loops. PG9 recognition involves electrostatic, sequence-independent and glycan interactions: the latter account for over half the interactive surface but are of sufficiently weak affinity to avoid autoreactivity. The structures of V1/V2-directed antibodies CH04 and PGT145 indicate that they share a common mode of glycan penetration by extended anionic loops. In addition to structurally defining V1/V2, the results thus identify a paradigm of antibody recognition for highly glycosylated antigens, which-with PG9-involves a site of vulnerability comprising just two glycans and a strand.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available